Cleared Traditional

K821931 - ZETA-CORT

K821931 is an FDA 510(k) clearance for ZETA-CORT, manufactured by Amf Biological and Diagnostics Co.. The device is a Class 2 Chemistry device with product code CGR cleared through the Traditional 510(k) pathway after a 23-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1982
Decision
23d
Days
Class 2
Risk

K821931 is an FDA 510(k) clearance for the ZETA-CORT. Classified as Radioimmunoassay, Cortisol (product code CGR), Class II - Special Controls.

Submitted by Amf Biological and Diagnostics Co. (Mchenry, US). The FDA issued a Cleared decision on July 22, 1982 after a review of 23 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1205 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K821931

510(k) Number K821931 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 29, 1982
Decision Date July 22, 1982
Days to Decision 23 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 89d · This submission: 23d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CGR Device Classification - Class 2, Special Controls

Product Code CGR Radioimmunoassay, Cortisol
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1205
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGR Radioimmunoassay, Cortisol

All 83
Devices cleared under the same product code (CGR) and FDA review panel - the closest regulatory comparables to K821931.
CORTISOL KIT
K830148 · Cambridge Medical Technology · Feb 1983
CORTISOL RIA KIT
K822892 · Antibodies, Inc. · Nov 1982
SOPHEIA CORTISOL EIA KIT
K822845 · Diagnostic Products Corp. · Oct 1982
DSL 1020
K821068 · Diagnostic Systems Laboratories, Inc. · May 1982
CORTISOL-SQUIBB RADIOIMMUNOASSAY KIT
K820341 · E. R. Squibb & Sons, Inc. · Mar 1982
CORTISOL (RIA) KIT
K820074 · Immuno Assay Corp. · Jan 1982